{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:57Z","timestamp":1772136537000,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China, Youth Project","award":["#82203367"],"award-info":[{"award-number":["#82203367"]}]},{"name":"National Natural Science Foundation of China, Youth Project","award":["#82203403"],"award-info":[{"award-number":["#82203403"]}]},{"name":"National Natural Science Foundation of China, Youth Project","award":["#82101838"],"award-info":[{"award-number":["#82101838"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302304"],"award-info":[{"award-number":["82302304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Doctoral Workstation Foundation of Guangdong Second Provincial General Hospital, China","award":["2022BSGZ011"],"award-info":[{"award-number":["2022BSGZ011"]}]},{"name":"Tongji University Medicine-XInterdisciplinaryResearch Initiative","award":["2025-0553-YB-02"],"award-info":[{"award-number":["2025-0553-YB-02"]}]},{"name":"National Key Research and Development Program of China","award":["#2022YFB3804504"],"award-info":[{"award-number":["#2022YFB3804504"]}]},{"name":"Experimental Animal Fund of Shanghai Science and Technology Commission","award":["#22140903800"],"award-info":[{"award-number":["#22140903800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02091-2","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T02:33:46Z","timestamp":1765679626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative molecular\u2013radiopathomic characterization of AIRE-driven immune subtypes in bladder cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Ji","family":"Liu","sequence":"first","affiliation":[]},{"given":"Shuwen","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Zhuoran","family":"Gu","sequence":"additional","affiliation":[]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Shiyu","family":"Mao","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[]},{"given":"Zongtai","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"2091_CR1","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.7150\/jca.28989","volume":"10","author":"CZ Zhu","year":"2019","unstructured":"Zhu, C. Z., Ting, H. N., Ng, K. H. & Ong, T. A. A review on the accuracy of bladder cancer detection methods. J. Cancer 10, 4038\u20134044 (2019).","journal-title":"J. Cancer"},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.eururo.2009.01.002","volume":"55","author":"A Stenzl","year":"2009","unstructured":"Stenzl, A. et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 55, 815\u2013825 (2009).","journal-title":"Eur. Urol."},{"key":"2091_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152\u2013165 (2014).","journal-title":"Cancer Cell"},{"key":"2091_CR4","doi-asserted-by":"publisher","unstructured":"Maiorano, B. A. et al. Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day. Biomedicines 10, https:\/\/doi.org\/10.3390\/biomedicines10020411 (2022).","DOI":"10.3390\/biomedicines10020411"},{"key":"2091_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.eururo.2019.10.004","volume":"77","author":"A G\u00f3mez de Lia\u00f1o Lista","year":"2020","unstructured":"G\u00f3mez de Lia\u00f1o Lista, A. et al. Clinical outcome after progressing to frontline and second-line anti-PD-1\/PD-L1 in advanced urothelial cancer. Eur. Urol. 77, 269\u2013276 (2020).","journal-title":"Eur. Urol."},{"key":"2091_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02212-7","volume":"24","author":"BH Alsaafeen","year":"2025","unstructured":"Alsaafeen, B. H., Ali, B. R. & Elkord, E. Resistance mechanisms to immune checkpoint inhibitors: updated insights. Mol. Cancer 24, 20 (2025).","journal-title":"Mol. Cancer"},{"key":"2091_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","volume":"7","author":"S Gettinger","year":"2017","unstructured":"Gettinger, S. et al. Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer. Cancer Discov. 7, 1420\u20131435 (2017).","journal-title":"Cancer Discov."},{"key":"2091_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trecan.2024.11.011","volume":"11","author":"K Ma","year":"2025","unstructured":"Ma, K. et al. Turning cold into hot: emerging strategies to fire up the tumor microenvironment. Trends Cancer 11, 117\u2013134 (2025).","journal-title":"Trends Cancer"},{"key":"2091_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2019.05.017","volume":"458","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Lett. 458, 123\u2013135 (2019).","journal-title":"Cancer Lett."},{"key":"2091_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0800-6","volume":"17","author":"HY Tan","year":"2018","unstructured":"Tan, H. Y. et al. Targeting tumour microenvironment by tyrosine kinase inhibitor. Mol. Cancer 17, 43 (2018).","journal-title":"Mol. Cancer"},{"key":"2091_CR11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.7150\/ijbs.25720","volume":"14","author":"S Guo","year":"2018","unstructured":"Guo, S. & Deng, C. X. Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation. Int. J. Biol. Sci. 14, 2083\u20132093 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"2091_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12865","volume":"53","author":"YQ Cheng","year":"2020","unstructured":"Cheng, Y. Q. et al. Modifying the tumour microenvironment and reverting tumour cells: new strategies for treating malignant tumours. Cell Prolif. 53, e12865 (2020).","journal-title":"Cell Prolif."},{"key":"2091_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791924","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. A novel TGF-\u03b2 risk score predicts the clinical outcomes and tumour microenvironment phenotypes in bladder cancer. Front. Immunol. 12, 791924 (2021).","journal-title":"Front. Immunol."},{"key":"2091_CR14","doi-asserted-by":"publisher","unstructured":"Upadhrasta, S. & Zheng, L. Strategies in developing immunotherapy for pancreatic cancer: recognizing and correcting multiple immune \u201cdefects\u201d in the tumor microenvironment. J. Clin. Med. 8, https:\/\/doi.org\/10.3390\/jcm8091472 (2019).","DOI":"10.3390\/jcm8091472"},{"key":"2091_CR15","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1080\/15476286.2021.1877024","volume":"18","author":"M Kurkowiak","year":"2021","unstructured":"Kurkowiak, M. et al. The effects of RNA editing in cancer tissue at different stages in carcinogenesis. RNA Biol. 18, 1524\u20131539 (2021).","journal-title":"RNA Biol."},{"key":"2091_CR16","doi-asserted-by":"publisher","unstructured":"Hosaka, T., Tsuji, H. & Kwak, S. RNA editing: a new therapeutic target in amyotrophic lateral sclerosis and other neurological diseases. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms222010958 (2021).","DOI":"10.3390\/ijms222010958"},{"key":"2091_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15476286.2020.1867797","volume":"18","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Okada, S. & Sakurai, M. Adenosine-to-inosine RNA editing in neurological development and disease. RNA Biol. 18, 999\u20131013 (2021).","journal-title":"RNA Biol."},{"key":"2091_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-biochem-060208-105251","volume":"79","author":"K Nishikura","year":"2010","unstructured":"Nishikura, K. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 79, 321\u2013349 (2010).","journal-title":"Annu. Rev. Biochem."},{"key":"2091_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13000-017-0600-0","volume":"12","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Wang, H., Lin, W. & Shuai, P. ADAR1 overexpression is associated with cervical cancer progression and angiogenesis. Diagn. Pathol. 12, 12 (2017).","journal-title":"Diagn. Pathol."},{"key":"2091_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nm.3043","volume":"19","author":"L Chen","year":"2013","unstructured":"Chen, L. et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 19, 209\u2013216 (2013).","journal-title":"Nat. Med."},{"key":"2091_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","volume":"28","author":"L Han","year":"2015","unstructured":"Han, L. et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 28, 515\u2013528 (2015).","journal-title":"Cancer Cell"},{"key":"2091_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak, K. G. K. et al. Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharm. Res. 153, 104683 (2020).","journal-title":"Pharm. Res."},{"key":"2091_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A. et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur. Urol. 77, 420\u2013433 (2020).","journal-title":"Eur. Urol."},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MOU.0000000000000641","volume":"29","author":"U Satyal","year":"2019","unstructured":"Satyal, U., Sikder, R. K., McConkey, D., Plimack, E. R. & Abbosh, P. H. Clinical implications of molecular subtyping in bladder cancer. Curr. Opin. Urol. 29, 350\u2013356 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"2091_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-020-0263-4","volume":"9","author":"QW Zhang","year":"2020","unstructured":"Zhang, Q. W. et al. Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort. Clin. Transl. Med. 9, 12 (2020).","journal-title":"Clin. Transl. Med."},{"key":"2091_CR26","doi-asserted-by":"publisher","unstructured":"Sun, R. et al. Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells. J. Immunother. Cancer 8, https:\/\/doi.org\/10.1136\/jitc-2020-001429 (2020).","DOI":"10.1136\/jitc-2020-001429"},{"key":"2091_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1515\/jtim-2024-0035","volume":"12","author":"K Chen","year":"2024","unstructured":"Chen, K., Li, J. & Li, L. Artificial intelligence for disease X: progress and challenges. J. Transl. Int. Med. 12, 534\u2013536 (2024).","journal-title":"J. Transl. Int. Med."},{"key":"2091_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts, H. J. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 4006 (2014).","journal-title":"Nat. Commun."},{"key":"2091_CR29","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1007\/s00330-017-4759-2","volume":"27","author":"M Lee","year":"2017","unstructured":"Lee, M. et al. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur. Radio. 27, 3752\u20133758 (2017).","journal-title":"Eur. Radio."},{"key":"2091_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M. & Reuter, V. E. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur. Urol. 70, 106\u2013119 (2016).","journal-title":"Eur. Urol."},{"key":"2091_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48, 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"key":"2091_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"2091_CR33","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2017.14585","volume":"318","author":"B Ehteshami Bejnordi","year":"2017","unstructured":"Ehteshami Bejnordi, B. et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 318, 2199\u20132210 (2017).","journal-title":"JAMA"},{"key":"2091_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12474","volume":"7","author":"KH Yu","year":"2016","unstructured":"Yu, K. H. et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat. Commun. 7, 12474 (2016).","journal-title":"Nat. Commun."},{"key":"2091_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2019.05.023","volume":"119","author":"TJ Brinker","year":"2019","unstructured":"Brinker, T. J. et al. Deep neural networks are superior to dermatologists in melanoma image classification. Eur. J. Cancer 119, 11\u201317 (2019).","journal-title":"Eur. J. Cancer"},{"key":"2091_CR36","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/cas.14927","volume":"112","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. Cancer Sci. 112, 2905\u20132914 (2021).","journal-title":"Cancer Sci."},{"key":"2091_CR37","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in diagnosis and treatment of bladder cancer. BMJ 384, e076743 (2024).","journal-title":"BMJ"},{"key":"2091_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41585-022-00608-y","volume":"19","author":"YC Lee","year":"2022","unstructured":"Lee, Y. C. et al. The dynamic roles of the bladder tumour microenvironment. Nat. Rev. Urol. 19, 515\u2013533 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"2091_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958368","volume":"13","author":"Q Song","year":"2022","unstructured":"Song, Q., Zhou, R., Shu, F. & Fu, W. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Front. Immunol. 13, 958368 (2022).","journal-title":"Front. Immunol."},{"key":"2091_CR40","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.7150\/thno.45358","volume":"10","author":"T Lin","year":"2020","unstructured":"Lin, T. et al. Synergy of tumor microenvironment remodeling and autophagy inhibition to sensitize radiation for bladder cancer treatment. Theranostics 10, 7683\u20137696 (2020).","journal-title":"Theranostics"},{"key":"2091_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2018.12.009","volume":"444","author":"S Takeda","year":"2019","unstructured":"Takeda, S. et al. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer. Cancer Lett. 444, 127\u2013135 (2019).","journal-title":"Cancer Lett."},{"key":"2091_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","volume":"40","author":"JB da Costa","year":"2022","unstructured":"da Costa, J. B. et al. Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy. Urol. Oncol. 40, 287\u2013294 (2022).","journal-title":"Urol. Oncol."},{"key":"2091_CR43","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.21037\/tau.2020.03.13","volume":"9","author":"HW Kang","year":"2020","unstructured":"Kang, H. W., Kim, W. J., Choi, W. & Yun, S. J. Tumor heterogeneity in muscle-invasive bladder cancer. Transl. Androl. Urol. 9, 2866\u20132880 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"2091_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gde.2017.10.009","volume":"48","author":"X Xu","year":"2018","unstructured":"Xu, X., Wang, Y. & Liang, H. The role of A-to-I RNA editing in cancer development. Curr. Opin. Genet Dev. 48, 51\u201356 (2018).","journal-title":"Curr. Opin. Genet Dev."},{"key":"2091_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06405-9","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat. Commun. 9, 3919 (2018).","journal-title":"Nat. Commun."},{"key":"2091_CR46","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ccell.2018.03.026","volume":"33","author":"X Peng","year":"2018","unstructured":"Peng, X. et al. A-to-I RNA editing contributes to proteomic diversity in cancer. Cancer Cell 33, 817\u2013828.e817 (2018).","journal-title":"Cancer Cell"},{"key":"2091_CR47","doi-asserted-by":"crossref","unstructured":"Xia, J. et al. TGF\u03b2 signaling activation correlates with immune-inflamed tumor microenvironment across human cancers and predicts response to immunotherapy. Cell Cycle, 22, 57\u201372 (2022).","DOI":"10.1080\/15384101.2022.2109105"},{"key":"2091_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.omto.2021.03.014","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Secretion of bispecific protein of anti-PD-1 fused with TGF-\u03b2 trap enhances antitumor efficacy of CAR-T cell therapy. Mol. Ther. Oncolytics 21, 144\u2013157 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"2091_CR49","doi-asserted-by":"publisher","first-page":"e1581545","DOI":"10.1080\/2162402X.2019.1581545","volume":"8","author":"PO Gaudreau","year":"2019","unstructured":"Gaudreau, P. O. et al. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors. Oncoimmunology 8, e1581545 (2019).","journal-title":"Oncoimmunology"},{"key":"2091_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.849793","volume":"12","author":"CM Tilsed","year":"2022","unstructured":"Tilsed, C. M. et al. Retinoic acid induces an IFN-driven inflammatory tumour microenvironment, sensitizing to immune checkpoint therapy. Front. Oncol. 12, 849793 (2022).","journal-title":"Front. Oncol."},{"key":"2091_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"2091_CR52","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.20100637","volume":"207","author":"J Fourcade","year":"2010","unstructured":"Fourcade, J. et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207, 2175\u20132186 (2010).","journal-title":"J. Exp. Med."},{"key":"2091_CR53","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1158\/2326-6066.CIR-22-0896","volume":"11","author":"D Xiao","year":"2023","unstructured":"Xiao, D. et al. ANXA1 promotes tumor immune evasion by binding PARP1 and upregulating Stat3-induced expression of PD-L1 in multiple cancers. Cancer Immunol. Res. 11, 1367\u20131383 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"2091_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","volume":"21","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cell Mol. Immunol. 21, 47\u201359 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"2091_CR55","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1053\/j.gastro.2022.01.046","volume":"162","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. Helicobacter pylori-induced RASAL2 through activation of nuclear factor-\u03baB promotes gastric tumorigenesis via \u03b2-catenin signaling axis. Gastroenterology 162, 1716\u20131731.e1717 (2022).","journal-title":"Gastroenterology"},{"key":"2091_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0853-6","volume":"17","author":"Y Pan","year":"2018","unstructured":"Pan, Y. et al. RASAL2 promotes tumor progression through LATS2\/YAP1 axis of hippo signaling pathway in colorectal cancer. Mol. Cancer 17, 102 (2018).","journal-title":"Mol. Cancer"},{"key":"2091_CR57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia, Y., Shen, S. & Verma, I. M. NF-\u03baB, an active player in human cancers. Cancer Immunol. Res. 2, 823\u2013830 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"2091_CR58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi, N. et al. Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cell Mol. Life Sci. 81, 106 (2024).","journal-title":"Cell Mol. Life Sci."},{"key":"2091_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier, S., Gouwy, M. & Proost, P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol. Immunol. 20, 217\u2013251 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"2091_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57094-0","volume":"16","author":"Q Yang","year":"2025","unstructured":"Yang, Q. et al. The CXCL8\/MAPK\/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro. Nat. Commun. 16, 1715 (2025).","journal-title":"Nat. Commun."},{"key":"2091_CR61","doi-asserted-by":"publisher","unstructured":"Han, Z. J. et al. Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy. Molecules 27, https:\/\/doi.org\/10.3390\/molecules27010137 (2021).","DOI":"10.3390\/molecules27010137"},{"key":"2091_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s002620050605","volume":"49","author":"TS Collins","year":"2000","unstructured":"Collins, T. S., Lee, L. F. & Ting, J. P. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism. Cancer Immunol. Immunother. 49, 78\u201384 (2000).","journal-title":"Cancer Immunol. Immunother."},{"key":"2091_CR63","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1080\/21691401.2019.1664559","volume":"47","author":"T Yi","year":"2019","unstructured":"Yi, T. et al. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Artif. Cells Nanomed. Biotechnol. 47, 3765\u20133773 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"2091_CR64","doi-asserted-by":"publisher","first-page":"445","DOI":"10.21037\/tau.2020.02.16","volume":"9","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer. Transl. Androl. Urol. 9, 445\u2013451 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"2091_CR65","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1109\/JBHI.2019.2956351","volume":"24","author":"M Fan","year":"2020","unstructured":"Fan, M. et al. Joint prediction of breast cancer histological grade and Ki-67 expression level based on DCE-MRI and DWI radiomics. IEEE J. Biomed. Health Inf. 24, 1632\u20131642 (2020).","journal-title":"IEEE J. Biomed. Health Inf."},{"key":"2091_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejrad.2019.06.025","volume":"118","author":"Q Gu","year":"2019","unstructured":"Gu, Q. et al. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer. Eur. J. Radio. 118, 32\u201337 (2019).","journal-title":"Eur. J. Radio."},{"key":"2091_CR67","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jmri.25555","volume":"46","author":"XX Hu","year":"2017","unstructured":"Hu, X. X. et al. Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J. Magn. Reson. Imaging 46, 383\u2013392 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"2091_CR68","doi-asserted-by":"publisher","first-page":"16964","DOI":"10.3748\/wjg.v20.i45.16964","volume":"20","author":"S Kijima","year":"2014","unstructured":"Kijima, S. et al. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET\/CT. World J. Gastroenterol. 20, 16964\u201316975 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2091_CR69","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.tranon.2017.09.003","volume":"10","author":"HJ Meyer","year":"2017","unstructured":"Meyer, H. J., Schob, S., H\u00f6hn, A. K. & Surov, A. MRI texture analysis reflects histopathology parameters in thyroid cancer - a first preliminary study. Transl. Oncol. 10, 911\u2013916 (2017).","journal-title":"Transl. Oncol."},{"key":"2091_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-021-00433-3","volume":"21","author":"Z Zheng","year":"2021","unstructured":"Zheng, Z. et al. Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer. Cancer Imaging 21, 65 (2021).","journal-title":"Cancer Imaging"},{"key":"2091_CR71","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."},{"key":"2091_CR72","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/536217","volume":"2014","author":"TY Kim","year":"2014","unstructured":"Kim, T. Y., Cho, N. H., Jeong, G. B., Bengtsson, E. & Choi, H. K. 3D texture analysis in renal cell carcinoma tissue image grading. Comput. Math. Methods Med. 2014, 536217 (2014).","journal-title":"Comput. Math. Methods Med."},{"key":"2091_CR73","doi-asserted-by":"publisher","unstructured":"Bhattacharjee, S. et al. Multi-Features Classification of Prostate Carcinoma Observed in Histological Sections: Analysis of Wavelet-Based Texture and Colour Features. Cancers 11, https:\/\/doi.org\/10.3390\/cancers11121937 (2019).","DOI":"10.3390\/cancers11121937"},{"key":"2091_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.703033","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. A novel nomogram based on machine learning-pathomics signature and neutrophil to lymphocyte ratio for survival prediction of bladder cancer patients. Front. Oncol. 11, 703033 (2021).","journal-title":"Front. Oncol."},{"key":"2091_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66870-9","volume":"14","author":"GY Wang","year":"2024","unstructured":"Wang, G. Y. et al. Prediction of non-muscle invasive bladder cancer recurrence using deep learning of pathology image. Sci. Rep. 14, 18931 (2024).","journal-title":"Sci. Rep."},{"key":"2091_CR76","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1007\/s00330-020-06796-8","volume":"30","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study. Eur. Radio. 30, 4816\u20134827 (2020).","journal-title":"Eur. Radio."},{"key":"2091_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13688-x","volume":"25","author":"Z Zheng","year":"2025","unstructured":"Zheng, Z. et al. Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer. BMC Cancer 25, 310 (2025).","journal-title":"BMC Cancer"},{"key":"2091_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2022.102645","volume":"83","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. RetCCL: clustering-guided contrastive learning for whole-slide image retrieval. Med. Image Anal. 83, 102645 (2023).","journal-title":"Med. Image Anal."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02091-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02091-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02091-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:03:22Z","timestamp":1766073802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02091-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02091-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7288040\/v1","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"766"}}